LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: Recognition and diagnosis of mucopolysaccharidosis II (Hunter syndrome).

Martin, Rick / Beck, Michael / Eng, Christine / Giugliani, Roberto / Harmatz, Paul / Muñoz, Verónica / Muenzer, Joseph

Pediatrics

2008  Volume 121, Issue 2, Page(s) e377–86

Abstract: Mucopolysaccharidosis II, also known as Hunter syndrome, is a rare, X-linked disorder caused ... of glycosaminoglycans. In patients with mucopolysaccharidosis II, glycosaminoglycans accumulate within tissues and ... organs, contributing to the signs and symptoms of the disease. Mucopolysaccharidosis II affects multiple ...

Abstract Mucopolysaccharidosis II, also known as Hunter syndrome, is a rare, X-linked disorder caused by a deficiency of the lysosomal enzyme iduronate-2-sulfatase, which catalyzes a step in the catabolism of glycosaminoglycans. In patients with mucopolysaccharidosis II, glycosaminoglycans accumulate within tissues and organs, contributing to the signs and symptoms of the disease. Mucopolysaccharidosis II affects multiple organs and physiologic systems and has a variable age of onset and variable rate of progression. Common presenting features include excess urinary glycosaminoglycan excretion, facial dysmorphism, organomegaly, joint stiffness and contractures, pulmonary dysfunction, myocardial enlargement and valvular dysfunction, and neurologic involvement. In patients with neurologic involvement, intelligence is impaired, and death usually occurs in the second decade of life, whereas those patients with minimal or no neurologic involvement may survive into adulthood with normal intellectual development. Enzyme replacement therapy has emerged as a new treatment for mucopolysaccharidosis disorders, including Hunter syndrome. The purpose of this report is to provide a concise review of mucopolysaccharidosis II for practitioners with the hope that such information will help identify affected boys earlier in the course of their disease.
MeSH term(s) Diagnosis, Differential ; Female ; History, 20th Century ; Humans ; Male ; Mucopolysaccharidosis II/diagnosis ; Mucopolysaccharidosis II/genetics ; Mucopolysaccharidosis II/history ; Mucopolysaccharidosis II/therapy ; Pedigree
Language English
Publishing date 2008-02
Publishing country United States
Document type Historical Article ; Journal Article ; Review
ZDB-ID 207677-9
ISSN 1098-4275 ; 0031-4005
ISSN (online) 1098-4275
ISSN 0031-4005
DOI 10.1542/peds.2007-1350
Shelf mark
Um IV Zs.131: Show issues Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)
Zs.MO 357: Show issues
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top